The Dow Jones has lost more than 1,000 points since this time last month, and the S&P 500 is down 2.4% for the same time period.
Category
Pot Stocks
Here Are the Cannabis Earnings Reports I'm Watching in This Big Revenue Quarter
The past few months have seen some minor scandals push marijuana shares’ prices down, which is natural in a new industry like this.
Aphria, however, zoomed to an intraday high of $7.45 after announcing earnings.
The company increased its net cannabis revenue by 85%, which is a big deal – and it won’t be the only cannabis firm to do that.
The Complete Guide on Cannabis Stocks to Invest in for 2020
The cannabis revolution is here, and there’s still time for investors to jump into this lucrative market before it truly takes off.
To help you do just that, we’ve put together this guide on everything you need to know about investing in cannabis stocks in 2019.
I'm Ready to Reveal My Biggest High-Profit Secret Yet
Today, Tom’s very excited to show you a brand-new way of making money.
In fact, it’s something he’s very passionate about that he's never brought up before.
And now he thinks it's the perfect time to talk about it and show you what’s going on…
Here's What's Really Happening with Aphria's Stellar Earnings Report
Aphria reported its fiscal fourth-quarter earnings last week, and the company exceeded all expectations.
And it beat those estimates from underneath a cloud of short sellers' spurious innuendo, to boot.
After a quarter of overall decline in Canadian cannabis revenue, Aphria saw an increase of 85% – that's 85% sequentially and not year over year. The company also turned earnings before interest, tax, depreciation, and amortization (EBITDA) positive – albeit after adjustments and with help from a European pharmaceutical distribution business the company owns.
And to top it off, management's optimistic about the future.
So any investor could look at Aphria's reporting and conclude it had a great quarter. And they'd be dead on.
What might not be so obvious at first glance is that this company just showed investors how it was going to take the cannabis sector to the next level.
There’s much more here than meets the eye…
What Every Investor Needs to Know About the CannTrust Affair
For a supposedly "controversial" sector, legal cannabis has been refreshingly transparent and light on (actual) scandal, especially compared to, say, finance.
But there's always one…
CannTrust Holdings is a licensed cannabis producer in Canada; It's a popular stock that's seen 2019 highs of CA$14.87 (US$11.24) a share…
And those shares have slid 56% over the past month because of a mounting scandal.
There are $40 million worth of CannTrust products involved – and countless millions more in capital in play here.
Investors are wondering, so I'm going to show you what's happening here...
New York Just Gave Marijuana Stocks Another Massive Buy Signal
New York Governor Andrew Cuomo signed a bill on Monday decriminalizing marijuana possession in the state and expunging many past convictions.
The closer marijuana comes to looking like just about any other industry in America, the closer investors will get to hitting a home run owning pot stocks.
In the short term, stocks like this are the best to own…
This Company Is All About Isolating That Profitable "Certain Special Something" in Marijuana Plants
When you get right down to it, cannabinoids – the 113-plus compounds inside the cannabis plant – are what's powering the booming marijuana market and the profits everyone's taking in. Cannabinoids are the chemicals that give the plant its unique and highly sought-after effects. Cannabinoids can reduce inflammation and suppress seizures. They can relieve pain, […]
In fact, isolating and extracting those compounds is getting to be a multibillion-dollar business…
This U.S. Cannabis Firm Could Be Next on the Nasdaq
We've talked about some of the unique challenges facing legitimate United States-based cannabis companies – challenges that come from its illegal status at the federal level.
Banking is one challenge; marijuana firms in the states have an incredibly difficult time accessing those services for fear of running afoul of Uncle Sam's money laundering statutes.
Achieving a listing on the Nasdaq or New York Stock Exchange is another problem – and one with even more of an impact on investors. It effectively cuts off the company and its shareholders from the $20 trillion in capital that trades in the "big leagues."
Most American marijuana firms have to offer shares "on the pink sheets," in the smaller, markedly less liquid over-the-counter markets.
The other day, I showed you one U.S. cannabis company that took an ingenious "shortcut" route through a wall of red tape to list on the Nasdaq; it's the dawn of what I called a "$20 trillion tomorrow."
That tomorrow may come sooner than anyone realizes – because another American marijuana firm is making a play for its Nasdaq listing.
Here's what you need to know...
This Cannabis Sector “Classic Turnaround” Could Be Good for Another 100% in Profits
Sometimes a company just can’t seem to get it together due to a number of reasons.
And that’s a shame because some of these companies possess the infrastructure and expertise that, with the right leadership, could transform them into a gold mine, or a “turnaround.”
And now that we’re finally nearing the end of cannabis prohibition in the United States, there are a lot of promising changes underway at a few companies.